Buyers benchmarking, outsourcing meetings

[Joni Miyashiro]: It's very difficult. We try to stay within the pharmaceutical arena, because they have similar types of meetings with high numbers of external participants. It's difficult to benchmark against another company that docs not have the same type of meetings and has more internal events. You have to go out on a one-to-one basis and ask drilled-down questions about that company's meetings program. Even within the pharmaceutical industry, there's a lot of variation.